<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>We treated three <z:hpo ids='HP_0100724'>thrombophilia</z:hpo>-complicated pregnant women (two <z:hpo ids='HP_0003613'>antiphospholipid antibody</z:hpo> syndrome, one <z:hpo ids='HP_0005543'>protein C deficiency</z:hpo>) with low molecular weight <z:chebi fb="5" ids="28304">heparin</z:chebi> (dalteparin) </plain></SENT>
<SENT sid="1" pm="."><plain><z:hpo ids='HP_0000001'>All</z:hpo> three pregnancies including one twin pregnancy ended in live births without a decrease in bone mineral density </plain></SENT>
<SENT sid="2" pm="."><plain>This treatment modality was effective and safe preventing <z:mp ids='MP_0005048'>thrombosis</z:mp> during their pregnancies </plain></SENT>
</text></document>